Serial Number 76273539
Registration 2741053
710

Registration Progress

Application Filed
Jun 18, 2001
Under Examination
Approved for Publication
Apr 16, 2003
Published for Opposition
May 6, 2003
Registered
Jul 29, 2003

Trademark Image

Basic Information

Serial Number
76273539
Registration Number
2741053
Filing Date
June 18, 2001
Registration Date
July 29, 2003
Published for Opposition
May 6, 2003
Cancellation Date
March 7, 2010
Drawing Code
2000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Mar 7, 2010

Rights Holder

Pharmacyclics, Inc.

03
Address
995 E. Arques Avenue
Sunnyvale, CA 94085

Ownership History

Pharmacyclics, Inc.

Original Applicant
03
Sunnyvale, CA

Pharmacyclics, Inc.

Owner at Publication
03
Sunnyvale, CA

Pharmacyclics, Inc.

Original Registrant
03
Sunnyvale, CA

Legal Representation

Attorney
Vinit G. Kathardekar

USPTO Deadlines

Next Deadline
2936 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2003-07-29)
Due Date
July 29, 2033
Grace Period Ends
January 29, 2034

Application History

17 events
Date Code Type Description Documents
Mar 7, 2010 C8.. O CANCELLED SEC. 8 (6-YR) Loading...
Apr 10, 2008 CFIT O CASE FILE IN TICRS Loading...
Jul 29, 2003 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 6, 2003 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 16, 2003 NPUB O NOTICE OF PUBLICATION Loading...
Mar 9, 2003 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 3, 2003 MAIL I PAPER RECEIVED Loading...
Feb 3, 2003 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 29, 2002 CNRT O NON-FINAL ACTION MAILED Loading...
Nov 26, 2002 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Sep 26, 2002 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 20, 2002 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 31, 2002 CNFR O FINAL REFUSAL MAILED Loading...
Apr 4, 2002 MAIL I PAPER RECEIVED Loading...
Apr 4, 2002 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 11, 2001 CNRT F NON-FINAL ACTION MAILED Loading...
Sep 14, 2001 DOCK D ASSIGNED TO EXAMINER Loading...

Additional Information

Design Mark
The instant mark represents mechanism of action of a texaphyrin molecule as it interacts with a cancer cell. The ovals in the foreground, at the bottom, left side represent cancer cells. One texaphyrin molecule, depicted by a small pentagon with a "X" in the middle, can be seen in the foreground inside one of these cells. The main set of images, in the middle of the picture, shows a close-up of one of the cancer cells with a texaphyrin molecule in it. The zigzag line represents an intra-cellular reducing metabolite like ascorbate, etc. The little "ball" attached to the zigzag line represents an electron. The texaphyrin gets activated by interacting with radiation, depicted by the beam of light on the plus sign in the texaphyrin, and then strips the electron from the reducing metabolite and transfers it to the right side of the texaphyrin. The electron then interacts with a passing oxygen molecule, depicted on the right side of the picture as a round sphere. When oxygen accepts the electron that has been passed to it by the texaphyrin molecule, it changes into a hydrogen peroxide molecule, which is shown on the right side of the picture as a "fluffy" sphere. The large sphere in the top, right of the picture represents the cell's nucleus. It is included to show that the texaphyrin molecule and the described process take place outside of the cell's nucleus.